Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · IEX Real-Time Price · USD

1.195

+0.075 (6.70%)

At close: Jul 2, 2024, 4:00 PM

1.218

+0.023 (1.92%)

After-hours: Jul 2, 2024, 7:28 PM EDT

Gain Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	22	42	37	65	-	-
Market Cap Growth	6.76%	13.33%	-42.34%	-	-	-
Enterprise Value	10	26	18	29	-6	-0
PE Ratio	-	-1.89	-2.11	-4.64	-	-
PS Ratio	-	763.91	265.47	390.97	-	-
PB Ratio	2.50	3.35	1.97	1.85	-	-
P/FCF Ratio	-3.35	-2.23	-2.51	-5.18	-	-
P/OCF Ratio	-3.35	-2.23	-2.53	-5.22	-	-
EV/Sales Ratio	-	478.16	130.83	177.19	-216.16	-2.34
EV/EBITDA Ratio	-2.35	-1.19	-1.05	-2.11	1.75	0.04
EV/EBIT Ratio	-2.34	-1.19	-1.05	-2.11	1.75	0.04
EV/FCF Ratio	-2.71	-1.40	-1.24	-2.35	1.91	0.05
Debt / Equity Ratio	0.10	0.08	0.07	0.05	0.20	-0.46
Debt / EBITDA Ratio	-0.04	-0.05	-0.07	-0.12	-0.35	-0.10
Debt / FCF Ratio	-0.05	-0.05	-0.09	-0.13	-0.39	-0.11
Quick Ratio	2.53	3.39	4.88	14.45	3.55	0.35
Current Ratio	2.77	3.59	5.11	14.78	4.25	0.49
Asset Turnover	0	0.00	0.01	0.00	0.01	-
Interest Coverage	-	-	-	-	-	-105.44
Return on Equity (ROE)	-213.30%	-193.00%	-70.10%	-35.10%	-124.40%	-
Return on Assets (ROA)	-129.00%	-123.20%	-57.70%	-31.80%	-69.70%	-
Return on Capital (ROIC)	-224.53%	-163.56%	-88.21%	-37.96%	-46.62%	863.22%
Earnings Yield	-98.02%	-52.83%	-47.29%	-21.53%	-	-
FCF Yield	-84.55%	-44.79%	-39.82%	-19.32%	-	-
Buyback Yield / Dilution	-50.64%	-9.49%	-16.90%	-279.11%	-19.17%	-
Total Shareholder Return	-50.64%	-9.49%	-16.90%	-279.11%	-19.17%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).